For patients living with inflammatory bowel disease (IBD), persistent symptoms, repeated treatment failures and the need for lifelong therapy remain major challenges. InnoCare is developing ICP-B161, a bispecific antibody designed to block two inflam... Read more
For patients living with Fabry disease, progressive kidney damage can lead to dialysis, transplantation and serious long-term complications. Idorsia is developing lucerastat, an investigational oral therapy designed to address the underlying disease ... Read more
For military personnel and veterans diagnosed with cancer, accessing specialised testing and treatment options can be difficult, particularly when care is delayed by insurance restrictions or limited access to oncology specialists. SOTERIA Precis... Read more
For millions of women living with endometriosis, persistent pain can disrupt daily life, affect fertility and limit treatment choices. Existing hormonal therapies may provide relief but can cause significant side effects, highlighting the need for al... Read more
ArrayPatch Ltd (“ArrayPatch”), a biotech company developing innovative microneedle-based therapeutics, announced the successful completion of the second close of its seed financing round, securing an additional €1.6 million, bringing... Read more
Lonza, a global contract development and manufacturing organization, to acquire the CDMO business of Merck Transaction sharpens the focus of Merck’s Life Science business sector and provides the CDMO business with a strong platform for its... Read more
NanoImaging Services, a cryo-EM CRO, and Proteos, a protein production research partner, have announced the launch of TrueCourse Biosciences, an integrated CRO that brings together advanced capabilities to help pharmaceutical and biotechnolog... Read more
As cell and gene therapies progress towards broader commercialisation, scientific innovation alone is no longer enough. The next generation of therapies must be designed from the outset with potency, manufacturability, scalability, analytical... Read more
© 2026 Biopharma Boardroom. All Rights Reserved.
